NCT02360215
Clinical Trial Information
Trial Number: NCT02360215 (ClinicalTrials.gov)
Disease Type:
- Miscellaneous Neoplasm - Metastases, Distant (excluding specified site of origin)
Trial Title:
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
Study ID:
NRG-CC001
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02360215-D2 | This dataset contains toxicity data from trial NCT02360215 to reproduce the results in the primary publication (PubMed ID 32058845). Dataset NCT02360215-D1 contains baseline, treatment, efficacy, and health-related quality of life data for this publication. |
| NCT02360215-D1 | This dataset contains baseline, treatment, efficacy, and health-related quality of life data from trial NCT02360215 to reproduce the results in the primary publication (PubMed ID 32058845). Dataset NCT02360215-D2 contains toxicity data for this publication. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®